Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Appelbaum

Showing results (231-240 of 258) with videos related to

Pageof 26
Sort By:
American Journal of Clinical Pathology|September 1, 1982
Comparison of two methods for same-day identification of EnterobacteriaceaeP C Appelbaum, R R Arthur, M E Parker, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 27, 2002
Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacinC L Clark, K Nagai, T A Davies, et al.
Infection and Immunity|November 1, 1977
Pathogenic mechanisms of a non-agglutinable Vibrio cholerae strain: demonstration of invasive and enterotoxigenic propertiesR M Robins-Browne, C S Still, M Isaäcson, et al.
Journal of Clinical Microbiology|January 1, 1983
Enhanced detection of bacteremia with a new BACTEC resin blood culture mediumP C Appelbaum, D G Beckwith, J R Dipersio, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Antipneumococcal activity of ABT-773 compared to those of 10 other agentsT A Davies, L M Ednie, D M Hoellman, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Antipneumococcal activities of gemifloxacin compared to those of nine other agentsT A Davies, L M Kelly, G A Pankuch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2000
Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of lifeG A Syrogiannopoulos, I N Grivea, T A Davies, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenesK Nagai, T A Davies, L M Ednie, et al.
International Journal of Antimicrobial Agents|September 26, 2002
Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, ChileElizabeth L Palavecino, I Riedel, C Duran, et al.
Journal of Clinical Microbiology|February 1, 1984
Comparative evaluation of the API 20S system and the automicrobic system gram-positive identification card for species identification of streptococciP C Appelbaum, M R Jacobs, J I Heald, et al.
Pageof 26

Showing results (231-240 of 258) with videos related to

Sort By:
Pageof 26
American Journal of Clinical Pathology|September 1, 1982
Comparison of two methods for same-day identification of EnterobacteriaceaeP C Appelbaum, R R Arthur, M E Parker, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 27, 2002
Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacinC L Clark, K Nagai, T A Davies, et al.
Infection and Immunity|November 1, 1977
Pathogenic mechanisms of a non-agglutinable Vibrio cholerae strain: demonstration of invasive and enterotoxigenic propertiesR M Robins-Browne, C S Still, M Isaäcson, et al.
Journal of Clinical Microbiology|January 1, 1983
Enhanced detection of bacteremia with a new BACTEC resin blood culture mediumP C Appelbaum, D G Beckwith, J R Dipersio, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Antipneumococcal activity of ABT-773 compared to those of 10 other agentsT A Davies, L M Ednie, D M Hoellman, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Antipneumococcal activities of gemifloxacin compared to those of nine other agentsT A Davies, L M Kelly, G A Pankuch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2000
Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of lifeG A Syrogiannopoulos, I N Grivea, T A Davies, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenesK Nagai, T A Davies, L M Ednie, et al.
International Journal of Antimicrobial Agents|September 26, 2002
Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, ChileElizabeth L Palavecino, I Riedel, C Duran, et al.
Journal of Clinical Microbiology|February 1, 1984
Comparative evaluation of the API 20S system and the automicrobic system gram-positive identification card for species identification of streptococciP C Appelbaum, M R Jacobs, J I Heald, et al.
Pageof 26